Mualliflar

  • Boltayeva R.Sh., Boyburiyeva Sh.O.

##semicolon##

Mukoplazma pnevmoniya, yuqumli kasalliklar, diagnostika, serologik usullar, molekulyar-biologik usullar, molekulyar-genetik texnologiyalar

##submission.citations##

1. Abdulhadi B, Kiel J. MycoplasmaPneumonia. 2023 Jan 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 28613531.

2. Bolormaa E, Park JY, Choe YJ, Kang CR, Choe SA, Mylonakis E. Treatment of Macrolide-resistant Mycoplasmapneumoniae Pneumonia in Children: A Meta-analysis of Macrolides Versus Tetracyclines. Pediatr Infect Dis J. 2025 Mar 1;44(3):200-206. doi: 10.1097/INF.0000000000004568. Epub 2024 Oct 2. PMID: 39383346.

3. Chen C, Chen S, Yang C, Zhang X, Liu L, Wang Y, Cao M. Risk factors for refractory Mycoplasmapneumoniae in Chinese children: a meta-analysis. Front Pediatr. 2025 Jun 27;13:1512689. doi: 10.3389/fped.2025.1512689. PMID: 40656195; PM CID: PMC12245905.

4. Chen J, Jiang Y, Wang Y, Zeng G, Liu P, She J, Zhong K, Duan B, Huang H, Wen Y, Chen W. Unraveling the role of distinct cytoskeletal motility structures in Mycoplasmapneumoniae relatives. BMC Microbiol. 2025 Aug 29;25(1):562. doi: 10.1186/s12 866-025-04320-w. PMID: 40883708; PMCID: PMC1 2395765

5. Dumke R. Infektionen mit den humanpathogenen Mykoplasmenspezies M. genitalium und M.pneumoniae: Aktuelle epidemiologische Aspekte [Infections with the human pathogenic Mycoplasmaspecies M. genitalium and M.pneumoniae: Current epidemiological aspects]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Aug;68(8):932-939. German. doi: 10.1007/s00103-025-04052-2. Epub 2025 May 12. PMID: 40355732; PMCID: PMC12287123.

6. Feng J, Wu Z, Zhu W, Jin F, Zhao M, Zhong W, Dai C, He Y, Yan L, Wu S, Wang Y, Rui Y, Zheng L, Fu Q. A novel thermo-activated one-pot RPA-CRISPR-Cas12b assay for Mycoplasmapneumoniae POCT. Biosens Bioelectron. 2025 Nov 15;288:117839. doi: 10.1016/j.bios.2025.117839. Epub 2025 Jul 29. PMID: 40780172.

7. Frantz GF, McAninch SA. Mycoplasmapneumoniae–Induced Rash and Mucositis (MIRM). 2024 Apr 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30247835.

8. Gavaud A, Holub M, Asquier-Khati A, Faure K, Leautez-Nainville S, Le Moal G, Goehringer F, Luque Paz D, Arnould B, Gerber V, Martin-Blondel G, Declerck C, Gazaignes S, Blanchi S, Loubet P, Mrozek N, Perpoint T, Cresta M, Mailhe M, Bleibtreu A, Cazanave C, Bébéar C, Pourcher V, Tubach F, Palich R; MYCADO Study Group. Mycoplasmapneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational study. Lancet Infect Dis. 2025 Jul;25 (7):801-812. doi: 10.1016/S1473-3099(24)00805-3. Epub 2025 Feb 19. PMID: 39986287

9. Gómez-Manzanares M, Gónzalez-Vico VH, Montero-García M, Ceballos OA. Mycoplasmapneumoniae-Induced Mucositis Sine Rash: Case report in an adult patient. Sultan Qaboos Univ Med J. 2025 May 2;25(1):792-793. doi: 10.18295/2075-0528.2907. PMID: 40979600; PMCID: PMC12445303.

10. Lanao AE, Chakraborty RK, Pearson-Shaver AL. MycoplasmaInfections. 2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): Stat-Pearls Publishing; 2025 Jan–. PMID: 30725612.

11. Lang Houser M, Mancuso JB, Gudjonsson JE, Hristov AC, Lowe L, Chan MP. Mycoplasmapneumoniae-Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases. J Cutan Pathol. 2025 Nov 26. doi: 10.1111/cup.70028. Epub ahead of print. PMID: 41298285.

12. Li J, Huang H, Song Z, Chen S, Xu J, Yang J, Zheng C, Liu Y, Zhang J, Cao L, Liu Q, Li Q, Li M, Gu Z, Wang H. Palm-sized CRISPR sensing platform for on-site Mycoplasmapneumoniae detection. Biosens Bioelectron. 2025 Aug 1;281:117458. doi: 10.1016/ j.bios.2025.117458. Epub 2025 Apr 9. PMID: 4023 9471

13. Liang H, Chen Y, Zheng P. Mycoplasmapneumoniae infection and concurrent aquaporin-4-positive neuromyelitis optica spectrum disorder: a case report and literature review. BMC Pediatr. 2025 Oct 3;25(1):765. doi: 10.1186/s12887-025-06155-w. PMID: 41044712; PMCID: PMC12495817.

14. Ouchi K, Oishi T. Recent Global Trends of Macrolide-resistant Mycoplasmapneumoniae: Why Has the Macrolide-resistant Rate Decreased in Japan? Pediatr Infect Dis J. 2025 Dec 1;44(12):e446-e449. doi: 10.1097/INF.0000000000005019. Epub 2025 Oct 15. PMID: 41090939

15. Oyama I, Ishizuka K, Otsuki T, Motohashi I, Ie K, Okuse C. Mycoplasmapneumonia With Cavitary Lesions. Clin Case Rep. 2025 Oct 6;13(10):e71186. doi: 10.1002/ccr3.71186. PMID: 41064614; PMCID: PMC12500520.

16. Smith C, Ng K, Sih K, Mcalpine A, Goldman RD. Resistant Mycoplasmapneumoniae in children. Can Fam Physician. 2025 Jul-Aug;71(7-8):487-489. doi: 10.46747/cfp.710708487. PMID: 40730436; PMCID: PMC12312865.

17. Waldeck F, Kramer TS, Boutin S, Matten J, Kramer J, Rupp J. Re-emergence of Mycoplasmapneumoniae before and after COVID-19 pandemic in Germany. BMC Infect Dis. 2025 Mar 6;25(1):318. doi: 10.1186/s12879-025-10657-4. PMID: 400507 86; PMCID: PMC11884198.

18. Xie P, Zhang Y, Qin Y, Fang Y, Yang N, Bai Y, Zhi S, Niu W, Wang F, Yuan X. Macrolide resistance in Mycoplasmapneumoniae in adult patients. Front Cell Infect Microbiol. 2025 Mar 4;15:1496521. doi: 10.33 89/fcimb.2025.1496521. PMID: 40166372; PMCID: PMC11955812

19. You H, Yang B, Liu H, Wu W, Yu F, Lin N, Yang W, Hu B, Liu Y, Zou H, Hao S, Xiao Y, Xu T, Jiang Y. Unravelling distinct patterns of metagenomic surveillance and respiratory microbiota between two P1 genotypes of Mycoplasmapneumoniae. Emerg Microbes Infect. 2025 Dec;14(1):2449087. doi: 10.1080/22221751.2024.2449087. Epub 2025 Jan 13. PMID: 39760260; PMCID: PMC11730683.

20. Yuan L, Mingyue D, Zhou L. Analysis of the characteristics of mixed infections with Mycoplasmapneumoniae in children. Sci Rep. 2025 Mar 19; 15(1):9414. doi: 10.1038/s41598-025-94292-8. PM ID: 40108415; PMCID: PMC11923272.

21. Yun KW. Growing Threat of Macrolide-Resistant Mycoplasmapneumoniae Among Children: What We Know and What We Need. J Korean Med Sci. 2025 Oct;40(43):e317. https://doi.org/10.3346/ jkms.2025.40.e317

22. Yan C, Chen Y, Ren X, Jia X, Du B, Zhao H, Feng Y, Xue G, Cui J, Liu X, Yuan J. In vitro antimicrobial susceptibility of Mycoplasmapneumoniae isolates across different regions of China in 2023. JAC Antimicrob Resist. 2025 Jul 30;7(4):dlaf124. doi: 10.1093/jacamr/dlaf124. PMID: 40741382; PMCID: PMC12308128.

23. Zhang R, Zuo Y, Li S. Mycoplasmapneumoniae MPN606 induces inflammation by activating MAPK and NF-κB signaling pathways. Microb Pathog. 2025 Mar;200:107288. doi: 10.1016/j.micpath.20 25.107288. Epub 2025 Jan 11. PMID: 39805346.

24. Zuo Y, Zhang R, Li S. Reviewing advancement in Mycoplasmapneumoniae P30 adhesin protein provides insights for future diagnosis and treatment. Front Microbiol. 2024 Dec 13;15:1515291. doi: 10.3389/fmicb.2024.1515291. PMID: 3973518 8; PMCID: PMC11671514.

25. Zhao X, Lv J, Wu M, Wu Q. Clinical characteristics and risk factors for Mycoplasmapneumoniae pneumonia in children. Front Pediatr. 2024 Dec 23;12:1438631. doi: 10.3389/fped.2024.143 8631. PMID: 39764167; PMCID: PMC11701002